2022 Directory of Pharmaceutical Venture Capital & Private Equity Companies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–“The Directory of Pharmaceutical Venture Capital and Private Equity Companies 2022” directory was added to from ResearchAndMarkets.com offer.

This helpful resource brings together both venture capitalists and private equity investors involved in pharmaceuticals, biotechnology, and medical devices.

This edition has been extensively updated, providing valuable, current and detailed information for individuals, entrepreneurs and businesses around the world. The new edition is the most current and comprehensive picture of this dynamic industry to date.

All company profiles include specific data that creates a detailed picture of the company and its investment parameters. This database provides direct access to over 500 companies and thousands of partners with detailed contact details and detailed investment and fund data.

The Directory provides specific information on:

• Company name, address, telephone and fax numbers

• Managing partners with their diplomas, mandates and professional background

• Satellite offices

• Email addresses and websites

• Mission statement

• Average and minimum investments

• Fund size

• Investment Criteria/Stage Preferences

• Industry preferences and geographic preferences

• Portfolio companies

• Other locations

The industry categories included in this directory are:

• Medications

• Biotechnology

• Biopharmaceuticals

• Bulk Pharmaceuticals

• Drug development

• Medication administration

• Over-the-counter/health products

• Clinical research

• research

• Therapeutic

• Life sciences

• medical technology

This Directory will allow you to:

• Find companies that are specifically interested in your industry.

• Look for companies that match the level of investment you need. From $200,000 to $50 million, you will be able to generate a listing that suits your needs.

• Find which venture capitalists have funded specific companies.

For more information on this directory, visit https://www.researchandmarkets.com/r/gi4sww